Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04431869 · ClinicalTrials.gov registry record
In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 215
- Enrollment target
NCT04431869: Completed study, sponsored by University of Colorado, Denver.
NCT04431869 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 215 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04431869 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 215 participants
- Enrollment target
Study Summary
The pregnancy related pro-thrombotic state, in addition to the COVID-19 associated hypercoagulability may have unknown consequences to the developing fetus. Hence, this proposal seeks to address this question that may have important implications for women that contract this virus during gestation.
Primary Outcome
Evaluate rates of intestinal atresias and limb anomalies in neonates born to women that contract SARS-CoV-2 during pregnancy in the first 30 days of life
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 215 participants |
| Start Date | 2020-08-18 |
| Est. Completion | 2021-09-01 |
What the finished NCT04431869 record still lists
NCT04431869 is an observational study that tracks outcomes without assigning an intervention. The registered 215 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04431869 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04431869 about?
NCT04431869 is a clinical study titled "In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers". The pregnancy related pro-thrombotic state, in addition to the COVID-19 associated hypercoagulability may have unknown consequences to the developing fetus. Hence, this proposal seeks to address this question that may have important implications for women that contract this virus during gestation.
What is the current status of trial NCT04431869?
This trial is currently completed. The enrollment target is 215 participants. The study started on 2020-08-18. Estimated completion is 2021-09-01.
Who is sponsoring clinical trial NCT04431869?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05134012 · 215 participants · Phase 3
RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)
- NCT05169970 · 215 participants · Phase 2
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer
- NCT05197270 · 215 participants · Phase 1
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- NCT05230199 · 215 participants · NA
Sensory Optimization of the Hospital Environment
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI